Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age

Vaccine

Volumn 29, Issue 18, 2011, Pages 3431-3437

  Miller, E Kathryn ^a   Dumitrescu, Logan ^b   Cupp, Chelsea ^b   Dorris, Stacy ^a   Taylor, Sallee ^a   Sparks, Robert ^a   Fawkes, Diane ^a   Frontiero, Virginia ^c   Rezendes, Anne M ^c   Marchant, Colin ^c   Edwards, Kathryn M ^a   Crawford, Dana C ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atopy; Genomics; Influenza vaccine; Vaccination; Vaccine efficacy; Wheezing

Indexed keywords

GENOMIC DNA; INACTIVATED VACCINE; INFLUENZA VACCINE; TRIPLE VACCINE;

ALLELE; ARTICLE; ASTHMA; ATOPY; BREAST FEEDING; CHILD; CHROMOSOME 1; CHROMOSOME 17; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; DNA DETERMINATION; DRUG EFFICACY; FAMILY HISTORY; FEASIBILITY STUDY; FEMALE; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; HEALTH SURVEY; HEREDITY; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; WHEEZING;

ASTHMA; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 7; CLINICAL TRIALS AS TOPIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY SOUNDS; RISK FACTORS;

EID: 79954889477     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.071     Document Type: Article

References (44)

1. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(February (7)):685-696.
2. Cook I.F. Sex differences in injection site reactions with human vaccines. Hum Vaccin 2009, 5(7):441-449.
3. Rehman A., Ullah I., The BCG scar size in asthmatic and non-asthmatic children. J Pak Med Assoc 2009, 59(9):625-628.
4. Stanley J., Frey S.E., Taillon-Miller P., Guo J., Miller R.D., Koboldt D.C., et al. The immunogenetics of smallpox vaccination. J Infect Dis 2007, 196(July (2)):212-219.
5. Reif D.M., McKinney B.A., Motsinger A.A., Chanock S.J., Edwards K.M., Rock M.T., et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis 2008, 198(July (1)):16-22.
6. Lee Y.C., Newport M.J., Goetghebuer T., Siegrest C.A., Weiss H.A., Pollard A.J., et al. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins. Vaccine 2006, 24(June (25)):5335-5340.
7. Tan P.L., Jacobson R.M., Poland G.A., Jacobsen S.J., Pankratz V.S. Twin studies of immunogenicity-determining the genetic contribution to vaccine failure. Vaccine 2001, 19(March (17-19)):2434-2439.
8. Klein N.P., Fireman B., Enright A., Ray P., Black S., Dekker C.L. A role for genetics in the immune response to the varicella vaccine. Pediatr Infect Dis J 2007, 26(4):300-305.
9. Ovsyannikova I.G., Jacobson R.M., Poland G.A. Variation in vaccine response in normal populations. Pharmacogenomics 2004, 5(June (4)):417-427.
10. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Poland G.A. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella II vaccination. J Infect Dis 2005, 191(February (4)):515-519.
11. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., O'Byrne M.M., Poland G.A. Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 2009, 27(November (49)):6926-6931.
12. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004, 65(December (12)):1506-1515.
13. Ovsyannikova I.G., Pankratz V.S., Vierkant R.A., Jacobson R.M., Poland G.A. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis 2006, 193(March (5)):655-663.
14. Ovsyannikova I., Haralambieva I., Dhiman N., O'Byrne M.M., Pankratz V.S., Jacobson R.M., et al. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 2010, 201(January (2)):207-213.
15. Dhiman N., Haralambieva I.H., Kennedy R.B., Vierkant R.A., O'Byrne M.M., Ovsyannikova I.G., et al. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 2010, 62(April (4)):197-210.
16. Ovsyannikova I.G., Dhiman N., Haralambieva I.H., Vierkant R.A., O'Byrne M.M., Jacobson R.M., et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010, 127(2):207-221.
17. Gelder C.M., Lambkin R., Hart K.W., Fleming D., Williams O.M., Bunce M., et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002, 185(1):114-117.
18. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008, 26(Suppl. 4):D35-D40.
19. Carlson C.S., Heagerty P.J., Nord A.S., Pritchard D.K., Ranchalis J., Boguch J.M., et al. TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects. Hum Genet 2007, 121(1):65-75.
20. Carty C.L., Heagerty P., Nakayama K., McClung E.C., Lewis J., Lum D., et al. Inflammatory response after influenza vaccination in men with and without carotid artery disease. Arterioscler Thromb Vasc Biol 2006, 26(December (12)):2738-2744.
21. Tang Y.-W., Li H., Wu H., Shyr Y., Edwards K.M. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007, 196(October (7)):1021-1025.
22. Ellwood P., Asher M.I., Beasley R., Clayton T.O., Stewart A.W. The International Study of Asthma and Allergies in Childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis 2005, 9(1):10-16. and the ISAAC Steering Committee.
23. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(September (3)):559-575.
24. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002, 155:478-484.
25. Crestani E., Guerra S., Wright A.L., Halonen M., Martinez F.D. Parental asthma as a risk factor for the development of early skin test sensitization in children. J Allergy Clin Immunol 2004, 113(February (2)):284-290.
26. Guilbert T.W., Morgan W.J., Zeiger R.S., Bacharier L.B., Boehmer S.J., Krawiec M., et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004, 114(December (6)):1282-1287.
27. Guerra S., Wright A.L., Morgan W.J., Sherrill D.L., Holberg C.J., Martinez F.D. Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med 2004, 170(July (1)):78-85.
28. Li X., Howard T.D., Zheng S.L., Haselkorn T., Peters S.P., Meyers D.A., et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 2010, 125(February (2)):328-335.
29. Kim S.H., Cho B.Y., Park C.S., Shin E.S., Cho E.Y., Yang E.M., et al. Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy 2009, 39(2):203-212.
30. Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448(July (7152)):470-473.
31. Himes B.E., Hunninghake G.M., Baurley J.W., Rafaels N.M., Sleiman P., Strachan D.P., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009, 84(May (5)):581-593.
32. Hancock D.B., Romieu I., Shi M., Sienra-Monge J.J., Wu H., Chiu G.Y., et al. Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children. PLoS Genet 2009, 5(August (8)):e1000623.
33. Mathias R.A., Grant A.V., Rafaels N., Hand T., Gao L., Vergara C., et al. A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol 2010, 125(February (2)):336-346.
34. Sleiman P.M.A., Flory J., Imielinski M., Bradfield J.P., Annaiah K., Willis-Owen S.A., et al. Variants of DENND1B associated with asthma in children. N Engl J Med 2010, 362(January (1)):36-44.
35. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., et al. Effect of variation in CHI3L1 on serum YKL-40 level risk of asthma, and lung function. N Engl J Med 2008, 358(April (16)):1682-1691.
36. Weidinger S., Gieger C., Rodriguez E., Baurecht H., Mempel M., Klopp N., et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 2008, 4(August (8)):e1000166.
37. Castro-Giner F., Bustamante M., Ramon Gonzalez J., Kogevinas M., Jarvis D., Heinrich J., et al. A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). BMC Med Genet 2009, 10(1):128.
38. Gao L., Grant A.V., Rafaels N., Stockton-Porter M., Watkins T., Gao P., et al. Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma. J Allergy Clin Immunol 2007, 119(May (5)):1111-1118.
39. Flores C., Ma S.F., Maresso K., Ober C., Garcia J.G. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet Epidemiol 2007, 31(4):296-305.
40. Christie J.D., Ma S.F., Aplenc R., Li M., Lanken P.N., Shah C.V., et al. Variation in the MYLK gene is associated with development of acute lung injury after major trauma. Crit Care Med 2008, 36(10):2794-2800.
41. Kimura J., Deutsch G.H. Key mechanisms of early lung development. Pediatr Dev Pathol 2007, 10(5):335-347.
42. Yang K.D., Chang J.C., Chuang H., Liang H.M., Kuo H.C., Lee Y.S., et al. Gene-gene and gene-environment interactions on IgE production in prenatal stage. Allergy 2009, 65(June (6)):731-739.
43. Hwang Y., Chen E.Y., Gu Z.J., Chuang W.L., Yu M.L., Lai M.Y., et al. Genetic predisposition of responsiveness to therapy for chronic hepatitis C. Pharmacogenomics 2006, 7(July (5)):697-709.
44. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ionnidis J.P., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9(May (5)):356-369.